"Receptors, Cholinergic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology.
Descriptor ID |
D011950
|
MeSH Number(s) |
D12.776.543.750.720.360
|
Concept/Terms |
Receptors, Cholinergic- Receptors, Cholinergic
- Receptors, Acetylcholine
- Cholinoceptive Sites
- Sites, Cholinoceptive
- Receptors, ACh
- Cholinergic Receptors
- ACh Receptors
- Acetylcholine Receptors
- Cholinoceptors
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Cholinergic".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Cholinergic".
This graph shows the total number of publications written about "Receptors, Cholinergic" by people in this website by year, and whether "Receptors, Cholinergic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1995 | 2 | 0 | 2 |
1997 | 1 | 0 | 1 |
1998 | 1 | 0 | 1 |
1999 | 1 | 1 | 2 |
2000 | 3 | 1 | 4 |
2001 | 1 | 3 | 4 |
2002 | 1 | 0 | 1 |
2003 | 0 | 1 | 1 |
2005 | 2 | 2 | 4 |
2006 | 2 | 1 | 3 |
2007 | 1 | 0 | 1 |
2008 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2011 | 3 | 1 | 4 |
2012 | 1 | 1 | 2 |
2016 | 0 | 1 | 1 |
2017 | 1 | 1 | 2 |
2018 | 0 | 1 | 1 |
2019 | 1 | 0 | 1 |
2020 | 0 | 1 | 1 |
2022 | 0 | 1 | 1 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Cholinergic" by people in Profiles.
-
Acetylcholine receptor based chemogenetics engineered for neuronal inhibition and seizure control assessed in mice. Nat Commun. 2024 Jan 18; 15(1):601.
-
Occurrence, genetic diversity and zoonotic potential of Blastocystis sp. in forest musk deer (Moschus berezovskii) in Southwest China. Parasite. 2022; 29:34.
-
Single exercise stress reduces central neurotrophins levels and adenosine A1 and A2 receptors expression, but does not revert opioid-induced hyperalgesia in rats. Int J Dev Neurosci. 2020 Nov; 80(7):636-647.
-
Isolated vocal cord paralysis in two siblings with compound heterozygous variants in MUSK: Expanding the phenotypic spectrum. Am J Med Genet A. 2019 04; 179(4):655-658.
-
Efficiency measures the conversion of agonist binding energy into receptor conformational change. J Gen Physiol. 2019 04 01; 151(4):465-477.
-
Cycles of myofiber degeneration and regeneration lead to remodeling of the neuromuscular junction in two mammalian models of Duchenne muscular dystrophy. PLoS One. 2018; 13(10):e0205926.
-
Novel SEA and LG2 Agrin mutations causing congenital Myasthenic syndrome. Orphanet J Rare Dis. 2017 12 19; 12(1):182.
-
Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice. Autoimmunity. 2017 Sep; 50(6):346-353.
-
Injection of inactive Bordetella pertussis and complete Freund's adjuvant with Torpedo californica AChR increases the occurrence of experimental autoimmune myasthenia gravis in C57BL/6 mice. Autoimmunity. 2017 Aug; 50(5):293-305.
-
A cholinergic basal forebrain feeding circuit modulates appetite suppression. Nature. 2016 Oct 13; 538(7624):253-256.